Image pharmaphorum Editor Oncology Deep Dive: Oncology 2022 Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. White Papers Sponsored Ensuring successful digital outreach and retention in atopic... Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. Views & Analysis Medical Informatics and Rare Disease: a bridge between two w... Today’s rare disease landscape comprises of around 7,000 different diseases. Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was Load more results
Oncology Deep Dive: Oncology 2022 Eradicating cancer is an ambitious goal for oncologists and life science companies around the world.
White Papers Sponsored Ensuring successful digital outreach and retention in atopic... Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies.
Views & Analysis Medical Informatics and Rare Disease: a bridge between two w... Today’s rare disease landscape comprises of around 7,000 different diseases.
Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.